What are the grades of diastolic dysfunction, what do they signify clinically, and what are the common causes?

Diastolic Dysfunction Grades and Clinical Significance

Diastolic dysfunction is classified into three grades based on left ventricular filling pressures and relaxation patterns, with Grade I representing impaired relaxation with normal filling pressures, Grade II indicating pseudonormalization with elevated pressures, and Grade III reflecting restrictive filling with markedly elevated pressures—each carrying distinct prognostic implications for cardiovascular morbidity and mortality. 1

Grade Definitions and Hemodynamic Characteristics

Grade I (Impaired Relaxation)

• Characterized by: E/A ratio ≤0.8 with peak E velocity ≤50 cm/sec 1
• Filling pressures: Normal or low left atrial pressure (LAP) 1
• Clinical significance: Despite being labeled "mild," Grade I is not benign—it carries a 2.43-fold increased risk of cardiovascular mortality and 2.30-fold increased risk of dementia-related death even after adjusting for age and comorbidities 2
• Important caveat: Grade I can exist with elevated LVEDP while maintaining normal mean LAP, manifested by pulmonary vein flow alterations and the presence of a B-bump on M-mode 3

Grade II (Pseudonormalization)

• Characterized by: E/A ratio between 0.8 and 2.0, requiring additional parameters for diagnosis 1
• Diagnostic criteria: When ≥50% of the following meet cutoff values, Grade II is present 1:
  • Average E/e′ ratio >14
  • LA volume index >34 mL/m²
  • TR jet velocity >2.8 m/sec
  • Pulmonary vein S/D ratio <1 (in reduced EF patients) 1
• Filling pressures: Elevated LAP 1
• Clinical significance: Represents moderate diastolic dysfunction with compensatory increase in atrial pressures masking the underlying relaxation abnormality 4
• Critical pitfall: The "normal-appearing" Doppler pattern can easily lead to missed diagnosis of significant diastolic dysfunction 4

Grade III (Restrictive Filling)

• Characterized by: E/A ratio ≥2 with restrictive filling pattern AND abnormally reduced mitral annular e′ velocity (septal <7 cm/sec, lateral <10 cm/sec) 1
• Additional features: Deceleration time <150-160 msec, IVRT <50 msec 1
• Filling pressures: Markedly elevated LAP 1
• Clinical significance: Associated with the highest risk of major adverse cardiovascular events (MACEs) with a 1.71-fold increased odds of postoperative complications compared to Grades I and II 5
• Prognostic importance: Grade III carries poor outcomes in restrictive cardiomyopathy and represents severe, irreversible diastolic dysfunction 1

Common Causes by Grade Progression

Early Stage (Grade I) Causes

• Hypertensive heart disease (most common) 1
• Aging-related changes in myocardial relaxation 2
• Early infiltrative diseases: Initial stages of cardiac amyloidosis, sarcoidosis 1
• Diabetes mellitus and metabolic syndrome 6
• Coronary artery disease with preserved ejection fraction 1

Progressive Disease (Grade II) Causes

• Hypertrophic cardiomyopathy with increased LA pressures 1
• Advancing infiltrative cardiomyopathies: Progressing amyloidosis 1
• Chronic hypertension with LV remodeling 7
• Ischemic heart disease with diastolic impairment 1

Advanced Disease (Grade III) Causes

• Restrictive cardiomyopathies: Advanced cardiac amyloidosis, idiopathic restrictive cardiomyopathy 1
• End-stage hypertrophic cardiomyopathy 1
• Severe dilated cardiomyopathy with elevated filling pressures 1
• Advanced ischemic cardiomyopathy 1
• Note: Must distinguish from constrictive pericarditis, which shows normal or elevated e′ velocity (annulus reversus) 1

Critical Clinical Considerations

Diagnostic Pitfalls

• Indeterminate results: When only 50% of parameters meet cutoff values or only one parameter is available, LAP estimation is inconclusive 1
• HFpEF detection limitations: The 2016 ASE algorithm has a false-negative rate exceeding 60% in ambulatory HFpEF patients, with 32.8% graded as normal despite invasively confirmed elevated filling pressures 8
• Post-treatment changes: In hospitalized HFpEF patients, 25% show normal/Grade I acutely, increasing to 51.1% after recompensation—highlighting the dynamic nature of grading 8

Special Populations

• Hypertrophic cardiomyopathy: Use E/e′ >14, LA volume index >34 mL/m², Ar-A duration ≥30 msec, and TR velocity >2.8 m/sec; avoid parameters in patients with >moderate MR 1
• Reduced ejection fraction: Transmitral inflow pattern alone is often sufficient; deceleration time is a critical prognostic marker 1
• Cirrhotic patients: Pre-TIPS diastolic dysfunction by 2020 criteria (not 2005 criteria) predicts 6.7-fold increased cardiovascular events and 7.4-fold increased liver dysfunction post-procedure 6

Prognostic Implications

• Mortality risk: Even Grade I diastolic dysfunction confers a 4.05-fold increased all-cause mortality risk over 20 years 2
• Cognitive decline: LV remodeling and diastolic dysfunction independently predict accelerated decline in executive function and memory 7
• Surgical risk: Grade III patients have significantly elevated perioperative MACE rates requiring intensive monitoring 5

Validation Maneuvers

• Valsalva maneuver: In Grade II, E/A ratio decreases to <0.8 (impaired relaxation pattern), confirming elevated filling pressures 1
• Exercise stress imaging: Only 9.5% of Grade I HFpEF patients meet ASE stress criteria, indicating poor sensitivity for exercise-induced elevation 8